All In MedTech

FDA Clearance Tracker · P000043-S014

THERMATRX TMX-2000 BPH THERMOTHERAPY SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 28, 2006 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 28, 2006

Approved

Time to decision

26 days

Received Mar 2, 2006. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P000043-S014
Device name
THERMATRX TMX-2000 BPH THERMOTHERAPY SYSTEM
Applicant location
Marlboro, MA
Received
Mar 2, 2006
Decided
Mar 28, 2006
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P000043

Device type

Device class
Class III

Every decision under product code MEQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A TRANSFER OF PACKAGING SITE OF THE RECTAL PROBES TO AMERICAN MEDICAL SYSTEMS, MINNETONKA, MINNESOTA AND TO GENERATE PACKAGE LABELS IN HOUSE.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.